FINNENCE ▪ THE WIRE FILE
THE WIRE · № 78430
News■ Unclear/unknown
Paradigm Therapeutics, Inc. Nominated for the Second Straight Year for the Prestigious 2026 Prix Galien USA "Best Start-Up" Award for SD-101 (Zorblesia™), a Topical Therapy for Treating the Entire Skin Surface of Patients with Epidermolysis Bullosa (EB)
KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Award nomination for a topical therapy; recognition without disclosed financial or regulatory milestone.
Promotional award news, no fundamental catalyst
CATALYST TO WATCH
Regulatory filing or trial results
MAIN RISK
Award does not imply approval or sales
FULL DISPATCH
SD-101 (Zorblesia™) is the First Topical Therapy Developed to Treat Wounds and Lesions Across the Entire Skin Surface of All Epidermolysis Bullosa (EB) Subtypes This second consecutive nomination places our company and focus on Epidermolysis Bullosa among a select group of visionaries...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
10x Genomics to Report Third Quarter 2026 Financial Results on November 5, 20262026-10-13 20:05 UTC
10x Genomics to Report Third Quarter 2026 Financial Results on November 5, 20262026-10-13 20:05 UTC
←CORRELATIONshares Healthcare
New Phase 3 trial: To Evaluate HU-045 With Moderate to Severe Glabellar Lines — Huons Biopharma2026-10-13 12:00 UTC
New Phase 3 trial: To Evaluate HU-045 With Moderate to Severe Glabellar Lines — Huons Biopharma2026-10-13 12:00 UTC
←CORRELATIONshares Healthcare
New Phase 3 trial: Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight — Amgen2026-10-13 12:00 UTC
New Phase 3 trial: Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight — Amgen2026-10-13 12:00 UTC
←CORRELATIONshares Healthcare
Walmart to cover some GLP-1s, inhalers and insulin for employees at no cost as it expands benefits2026-10-13 17:07 UTC
Walmart to cover some GLP-1s, inhalers and insulin for employees at no cost as it expands benefits2026-10-13 17:07 UTC
←CORRELATIONshares Healthcare
Behavior Frontiers Expands Autism Care Across Sacramento with Three New ABA Centers2026-10-13 17:15 UTC
Behavior Frontiers Expands Autism Care Across Sacramento with Three New ABA Centers2026-10-13 17:15 UTC
←CORRELATIONshares Healthcare
Merger aims for expanded safety net access to VBC data and tools2026-10-13 17:38 UTC
Merger aims for expanded safety net access to VBC data and tools2026-10-13 17:38 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.